This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Inventor Jia Xu
Introduction
Jia Xu is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biomedical research, particularly in the development of compounds that target serine threonine kinase (AKT). His work is crucial for advancing treatments for AKT-mediated diseases.
Latest Patents
Jia Xu holds a patent for "Serine threonine kinase (AKT) degradation/disruption compounds and methods of use." This patent discloses compounds that include an AKT ligand, a degradation/disruption tag, and a linker. These compounds are designed for use in the treatment of diseases associated with AKT.
Career Highlights
Jia Xu is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts his research. His innovative work has the potential to impact the treatment landscape for various diseases.
Collaborations
Jia Xu collaborates with esteemed colleagues, including Jian Jin and Jing Liu, who contribute to his research endeavors.
Conclusion
Jia Xu's contributions to the field of biomedical research through his innovative patents and collaborations highlight his role as a significant inventor in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile